• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Improved recovery from vaginal surgery with dexamethasone

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
June 7, 2015
in Obstetrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Use of dexamethasone prior to vaginal prolapse surgery for pelvic organ prolapse was associated with less postoperative nausea and vomiting.

2. Patients who received dexamethasone were more likely to pass postoperative voiding trials compared to those on placebo.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Vaginal reconstruction for pelvic organ prolapse (POP) is a common, minimally invasive surgery that can vastly improve a woman’s quality of life. Further, it often requires only a one-day hospital stay and is associated with less morbidity than abdominal surgery. However, postoperative complications, like pain, nausea, and vomiting can complicate recovery and delay discharge. Dexamethasone is a widely used steroid that is inexpensive and has an excellent safety profile. Multiple studies demonstrated that dexamethasone is effective at improving postoperative nausea and pain in a range of surgeries, from cesarean sections, to laparoscopic gallbladder removal. It has never, however, been studied specifically in vaginal surgery for POP and can be associated with complications such as short-term immunosuppression and insulin resistance. In the present work, researchers assessed whether dexamethasone administration prior to general anesthesia was associated with improved recovery among women undergoing vaginal prolapse surgery.

Patients who received dexamethasone experienced an improved recovery as measured by post-operative nausea, emesis, and ability to void. Strengths of this double-blinded, randomized placebo-controlled trial included rigorous study design. Limitations included small sample size and exclusion of women with medical comorbidities (e.g. poorly controlled diabetes) which limits external validity, particularly since a plurality of women undergoing vaginal prolapse surgery are poor candidates for invasive surgery due to their comorbid conditions. Future studies might employ a larger patient population that includes women with medical morbidities to help answer this question.

Click to read the study in AJOG

RELATED REPORTS

Brentuximab-based chemotherapy improves survival and reduces toxicity in patients with advanced Hodgkin lymphoma

#VisualAbstract: Belantamab Mafodotin, Pomalidomide, and Dexamethasone Improve Outcomes in Multiple Myeloma

#VisualAbstract: Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Relevant Reading: Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section

In-Depth [randomized controlled trial]: Women undergoing vaginal reconstructive surgery for POP were randomized to receive 8mg IV dexamethasone (n = 27) or placebo (n = 36) 60 minutes prior to surgery. The primary outcome was difference in Quality of Recovery (QoR-40) score 1 day postoperatively, where a lower difference indicates less symptomatology. Secondary outcomes included nausea and vomiting (PONV score) and Visual Analog Scales (VAS) for nausea/vomiting and pain.

Postoperatively, patients who received placebo were more likely to require antiemetics (11 vs 2, p = 0.029) and fail voiding trials (30 vs. 15; p = 0.037) compared to those randomized to dexamethasone. Those who received dexamethasone had a smaller decline in the QoR-40 “emotional state” domain (p = 0.04) and a lower VAS score for nausea/vomiting (p = 0.04). No adverse effects were noted among women randomized to dexamethasone.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: dexamethasonepelvic organ prolapse (POP)
Previous Post

Magnesium not associated with neuroprotection in preterm chorioamnionitis

Next Post

Nonlinear relationship between maternal hemoglobin and infant development

RelatedReports

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer
Chronic Disease

Brentuximab-based chemotherapy improves survival and reduces toxicity in patients with advanced Hodgkin lymphoma

August 28, 2024
#VisualAbstract: Belantamab Mafodotin, Pomalidomide, and Dexamethasone Improve Outcomes in Multiple Myeloma
StudyGraphics

#VisualAbstract: Belantamab Mafodotin, Pomalidomide, and Dexamethasone Improve Outcomes in Multiple Myeloma

June 13, 2024
#VisualAbstract: Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
StudyGraphics

#VisualAbstract: Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

December 20, 2023
Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men
Chronic Disease

Dexamethasone does not improve tuberculous meningitis survival in HIV

November 14, 2023
Next Post
Nonlinear relationship between maternal hemoglobin and infant development

Nonlinear relationship between maternal hemoglobin and infant development

Youth weapon violence linked to psychological consequences

Youth weapon violence linked to psychological consequences

Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk

Pediatric vesicoureteral reflux, bowel/bladder dysfunction increase recurrent UTI risk

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk
  • St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes
  • Glucagon-like peptide-1 receptor agonists may increase risk of reflux in patients with type 2 diabetes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.